Neil Martinson to Anti-HIV Agents
This is a "connection" page, showing publications Neil Martinson has written about Anti-HIV Agents.
Connection Strength
2,674
-
Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):577-579.
Score: 0,312
-
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med. 2009 Oct; 6(10):e1000172.
Score: 0,182
-
Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS. 2009 Apr 27; 23(7):809-16.
Score: 0,176
-
Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr. 2007 Jun 01; 45(2):206-9.
Score: 0,154
-
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):148-53.
Score: 0,150
-
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial. EBioMedicine. 2023 Jul; 93:104648.
Score: 0,117
-
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin. AIDS. 2023 09 01; 37(11):1651-1659.
Score: 0,117
-
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe. J Int AIDS Soc. 2022 08; 25(8):e25975.
Score: 0,110
-
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa. Front Immunol. 2022; 13:965214.
Score: 0,110
-
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
Score: 0,101
-
Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial. Trials. 2020 Oct 30; 21(1):900.
Score: 0,098
-
Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment. AIDS Behav. 2019 Jul; 23(7):1689-1697.
Score: 0,089
-
The effect of partner HIV status on motivation to take antiretroviral and isoniazid preventive therapies: a conjoint analysis. AIDS Care. 2018 10; 30(10):1298-1305.
Score: 0,081
-
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. J Antimicrob Chemother. 2017 07 01; 72(7):2028-2034.
Score: 0,077
-
Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure. AIDS Res Hum Retroviruses. 2017 01; 33(1):33-40.
Score: 0,073
-
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa. J Acquir Immune Defic Syndr. 2016 Jan 01; 71(1):31-7.
Score: 0,070
-
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection. J Infect Dis. 2015 Jan 15; 211(2):197-205.
Score: 0,063
-
Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. J Acquir Immune Defic Syndr. 2013 May 01; 63(1):105-11.
Score: 0,058
-
The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. Clin Infect Dis. 2013 Feb; 56(4):587-97.
Score: 0,056
-
Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS. 2011 Nov 13; 25(17):2177-81.
Score: 0,052
-
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women. Antivir Ther. 2012; 17(2):327-36.
Score: 0,052
-
When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009 Aug 04; 151(3):157-66.
Score: 0,045
-
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009 Mar 13; 23(5):631-6.
Score: 0,044
-
Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa. J Acquir Immune Defic Syndr. 2009 Mar 01; 50(3):327-30.
Score: 0,043
-
Comparative costs of inpatient care for HIV-infected and uninfected children and adults in Soweto, South Africa. J Acquir Immune Defic Syndr. 2007 Dec 01; 46(4):410-6.
Score: 0,040
-
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A. 2006 May 02; 103(18):7094-9.
Score: 0,036
-
Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis. 2005 Jul 01; 192(1):16-23.
Score: 0,034
-
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Ann Intern Med. 2021 10; 174(10):1367-1376.
Score: 0,026
-
Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. AIDS. 2020 01 01; 34(1):63-71.
Score: 0,023
-
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
Score: 0,020
-
Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections. J Infect Dis. 2011 Mar 15; 203(6):798-802.
Score: 0,012
-
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):26-35.
Score: 0,012
-
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. J Infect Dis. 2009 May 01; 199(9):1301-9.
Score: 0,011
-
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):538-43.
Score: 0,011
-
A model of directional selection applied to the evolution of drug resistance in HIV-1. Mol Biol Evol. 2007 Apr; 24(4):1025-31.
Score: 0,009
-
Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost. Clin Infect Dis. 2006 Jun 15; 42(12):1772-80.
Score: 0,009